We are live on ! Find out more
ACM

AIGH Capital Management Portfolio holdings

AUM $1.59B
1-Year Est. Return 855.46%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+855.46%
3 Year Est. Return
+3,007.26%
5 Year Est. Return
+4,204.76%
10 Year Est. Return
–
AUM
$322M
AUM Growth
-$58.3M
Cap. Flow
-$59.9M
Cap. Flow %
-18.61%
Top 10 Hldgs %
67.93%
Holding
59
New
12
Increased
10
Reduced
16
Closed
5

Top Buys

Rank Stock Value
1
INDI icon
indie Semiconductor
INDI
+$10.8M
2
TELA icon
TELA Bio
TELA
+$10.1M
3
MTRN icon
Materion
MTRN
+$4.95M
4
AVNW icon
Aviat Networks
AVNW
+$3.84M
5
APEN
Apollo Endosurgery, Inc.
APEN
+$2.82M

Top Sells

Rank Stock Value
1
CYBE
Cyberoptics Corp
CYBE
+$17.8M
2
SCPH
scPharmaceuticals
SCPH
+$3.15M
3
MRAM icon
Everspin Technologies
MRAM
+$2.74M
4
ARDX icon
Ardelyx
ARDX
+$2.18M
5
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
+$1.6M

Sector Composition

Rank Sector Weight
1 Technology 37.83%
2 Healthcare 28.66%
3 Materials 6%
4 Industrials 1.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LPTH icon
26
Lightpath Technologies
LPTH
$783M
$2.18M 0.68%
2,039,832
– –
ARDX icon
27
Ardelyx
ARDX
$1.04B
$1.77M 0.55%
1,487,476
-2,285,945
-61% -$2.18M
XFOR icon
28
X4 Pharmaceuticals
XFOR
$406M
$1.71M 0.53%
33,257
– –
EOLS icon
29
Evolus
EOLS
$491M
$1.61M 0.5%
200,000
+27,408
+16% +$291K
CGRN
30
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$1.59M 0.5%
+900,000
New +$2.08M
RVLP
31
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$1.55M 0.48%
739,531
+654,538
+770% +$1.27M
CGTX icon
32
Cognition Therapeutics
CGTX
$97.6M
$1.52M 0.47%
798,335
-112,455
-12% -$234K
CNTX icon
33
Context Therapeutics
CNTX
$46.7M
$1.43M 0.45%
1,291,771
+100,000
+8% +$180K
RNAZ icon
34
TransCode Therapeutics
RNAZ
$4.52M
$1.42M 0.44%
2
– –
ADVM
35
DELISTED
Adverum Biotechnologies
ADVM
$1.14M 0.35%
+120,000
New +$1.58M
FKWL icon
36
Franklin Wireless
FKWL
$26.8M
$1.14M 0.35%
390,000
– –
VCNX
37
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$1.03M 0.32%
9,913
– –
MYO icon
38
Myomo
MYO
$50.7M
$999K 0.31%
617,179
– –
SLNO
39
DELISTED
Soleno Therapeutics
SLNO
$708K 0.22%
424,089
-1
-0% -$2
PCSA icon
40
Processa Pharmaceuticals
PCSA
$6.45M
$686K 0.21%
607
– –
CLRB icon
41
Cellectar Biosciences
CLRB
$20.1M
$586K 0.18%
5,814
-309
-5% -$44.4K
ABEO icon
42
Abeona Therapeutics
ABEO
$397M
$428K 0.13%
+140,644
New +$580K
NBSE
43
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$345K 0.11%
43,601
-7,778
-15% -$129K
CMBM
44
DELISTED
Cambium Networks
CMBM
$325K 0.1%
+19,182
New +$344K
ATNX
45
DELISTED
Athenex, Inc. Common Stock
ATNX
$269K 0.08%
+50,007
New +$514K
NLSPW
46
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$158K 0.05%
+633,361
New +$130K
SVREW
47
SaverOne 2014 Ltd Warrant
SVREW
$128K 0.04%
+428,330
New +$186K
CYTHW
48
DELISTED
Cyclo Therapeutics, Inc. Warrant
CYTHW
$77K 0.02%
+219,795
New +$114K
NLSPW
49
CALL
DELISTED
NLS Pharmaceutics Warrant
NLSPW
$49K 0.02%
194,060
-633,361
-77% -$130K
SVREW
50
CALL
SaverOne 2014 Ltd Warrant
SVREW
$42K 0.01%
+141,364
New +$61.5K
1
2
3

Similar funds

VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

AIGH Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, AIGH Capital Management held 59 positions worth $322M, down 15% from $380M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

AIGH Capital Management withdrew a net $59.9M in Q3 2022, closing 5 positions and reducing 16 holdings. Its most notable exit was Cyberoptics Corp, an estimated $17.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 30% a quarter earlier, followed by Healthcare and Materials.

Against the trend, AIGH Capital Management opened a new position in indie Semiconductor worth $10.6M.

  • AIGH Capital Management's largest Q3 2022 buy was indie Semiconductor: 1,452,766 shares worth $10.6M.
  • AIGH Capital Management added most to TELA Bio in Q3 2022, an estimated $10.1M increase.
  • AIGH Capital Management's biggest Q3 2022 reduction was scPharmaceuticals, cutting an estimated $3.15M.
  • AIGH Capital Management fully exited Cyberoptics Corp in Q3 2022, selling an estimated $17.8M.
  • AIGH Capital Management's ten largest holdings make up 68% of its $322M portfolio in Q3 2022.
  • AIGH Capital Management opened 12 new positions and closed 5 in Q3 2022.
  • AIGH Capital Management's portfolio value fell 15% quarter-over-quarter to $322M.

Based on AIGH Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.